Year: 2025
Type: article
Study design: Case Report
Abstract: S urgical procedures to improve body aesthetics have long been used worldwide.Breast augmentation is one of the most commonly performed aesthetic surgeries globally.However, due to the complications associated with surgeries, the costs, and the potential need for revisions, patients are seeking non-surgical alternatives.In recent years, AQUAfilling® filler has become widely used in breast and gluteal augmentation, which are among the most common aesthetic procedures.[1] Although AQUAfill-ing® filler is said to be biocompatible with human tissue, the number of associated complications continues to rise.This case series emphasizes the possible long-term complications of using AQUAfilling® filler in large areas such as the breasts and gluteal regions and the importance of managing these complications seriously. Materials and MethodsThis study focuses on three female patients who visited our clinic between 2022 and 2024, with a history of AQUAfilling® filler injection for breast and gluteal augmentation, and who experienced long-term major complications.The average age of the women is 37.7 years.Two women had undergone breast augmentation, and one had undergone gluteal augmentation with AQUAfilling® filler at an external facility.Case 1 -A 35-year-old female patient had undergone breast augmentation six years earlier, with 150 cc injected into one breast and a total of 300 cc bilaterally of AQUAfilling® filler.Two years after the procedure, she experienced swelling in the right breast, followed by redness and increased temperature in the left breast, leading her to seek medical help at an external facility (Fig. 1).A fillerIn recent years, the use of AQUAfilling® filler has become widespread, particularly in breast and gluteal augmentation, which are among the most common aesthetic surgical procedures.Although AQUAfilling® filler is claimed to be biocompatible with human tissue, the number of complications associated with it continues to increase.The invasion of AQUAfilling® filler into the parenchyma, as well as the toxicity and oncogenicity of its main component, polyacrylamide, remain uncertain and require further investigation.In this study, we present three female patients with a history of AQUAfilling® filler injection for breast and gluteal augmentation who experienced long-term major complications.We aim to emphasize the significance of long-term complications of AQUAfilling® filler material and contribute to the reconstruction options in managing these complications.
Author: Furkan Cestepe
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4411931026